Skip to main content

Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).

Publication ,  Journal Article
Walsh, CJ; Leggett, SR; Strohbehn, K; Pierce, RH; Sleasman, JW
Published in: Mar Drugs
June 10, 2008

Harmful algal blooms (HABs) of the toxic dinoflagellate, Karenia brevis, produce red tide toxins, or brevetoxins. Significant health effects associated with red tide toxin exposure have been reported in sea life and in humans, with brevetoxins documented within immune cells from many species. The objective of this research was to investigate potential immunotoxic effects of brevetoxins using a leukemic T cell line (Jurkat) as an in vitro model system. Viability, cell proliferation, and apoptosis assays were conducted using brevetoxin congeners PbTx-2, PbTx-3, and PbTx-6. The effects of in vitro brevetoxin exposure on cell viability and cellular metabolism or proliferation were determined using trypan blue and MTT (1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan), respectively. Using MTT, cellular metabolic activity was decreased in Jurkat cells exposed to 5 - 10 microg/ml PbTx-2 or PbTx-6. After 3 h, no significant effects on cell viability were observed with any toxin congener in concentrations up to 10 microg/ml. Viability decreased dramatically after 24 h in cells treated with PbTx-2 or -6. Apoptosis, as measured by caspase-3 activity, was significantly increased in cells exposed to PbTx-2 or PbTx-6. In summary, brevetoxin congeners varied in effects on Jurkat cells, with PbTx-2 and PbTx-6 eliciting greater cellular effects compared to PbTx-3.

Duke Scholars

Published In

Mar Drugs

DOI

EISSN

1660-3397

Publication Date

June 10, 2008

Volume

6

Issue

2

Start / End Page

291 / 307

Location

Switzerland

Related Subject Headings

  • Oxocins
  • Medicinal & Biomolecular Chemistry
  • Marine Toxins
  • Jurkat Cells
  • Humans
  • Dose-Response Relationship, Drug
  • Cell Survival
  • Cell Proliferation
  • Caspase 3
  • Apoptosis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Walsh, C. J., Leggett, S. R., Strohbehn, K., Pierce, R. H., & Sleasman, J. W. (2008). Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar Drugs, 6(2), 291–307. https://doi.org/10.3390/md20080014
Walsh, Catherine J., Stephanie R. Leggett, Kathryn Strohbehn, Richard H. Pierce, and John W. Sleasman. “Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).Mar Drugs 6, no. 2 (June 10, 2008): 291–307. https://doi.org/10.3390/md20080014.
Walsh CJ, Leggett SR, Strohbehn K, Pierce RH, Sleasman JW. Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar Drugs. 2008 Jun 10;6(2):291–307.
Walsh, Catherine J., et al. “Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).Mar Drugs, vol. 6, no. 2, June 2008, pp. 291–307. Pubmed, doi:10.3390/md20080014.
Walsh CJ, Leggett SR, Strohbehn K, Pierce RH, Sleasman JW. Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar Drugs. 2008 Jun 10;6(2):291–307.

Published In

Mar Drugs

DOI

EISSN

1660-3397

Publication Date

June 10, 2008

Volume

6

Issue

2

Start / End Page

291 / 307

Location

Switzerland

Related Subject Headings

  • Oxocins
  • Medicinal & Biomolecular Chemistry
  • Marine Toxins
  • Jurkat Cells
  • Humans
  • Dose-Response Relationship, Drug
  • Cell Survival
  • Cell Proliferation
  • Caspase 3
  • Apoptosis